• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Endocrine Adiponectin-FGF15/19 Axis in Ethanol-Induced Inflammation and Alcoholic Liver Injury.乙醇诱导的炎症和酒精性肝损伤中的内分泌脂联素-FGF15/19轴
Gene Expr. 2018 May 18;18(2):103-113. doi: 10.3727/105221617X15093738210295. Epub 2017 Nov 2.
2
MitoNEET Deficiency Alleviates Experimental Alcoholic Steatohepatitis in Mice by Stimulating Endocrine Adiponectin-Fgf15 Axis.线粒体膜电位相关蛋白2缺乏通过刺激内分泌型脂联素-Fgf15轴减轻小鼠实验性酒精性脂肪性肝炎
J Biol Chem. 2016 Oct 21;291(43):22482-22495. doi: 10.1074/jbc.M116.737015. Epub 2016 Aug 29.
3
Myeloid Cell-Specific Lipin-1 Deficiency Stimulates Endocrine Adiponectin-FGF15 Axis and Ameliorates Ethanol-Induced Liver Injury in Mice.骨髓细胞特异性脂肪酶 1 缺乏可刺激内分泌脂联素-FGF15 轴并改善小鼠乙醇诱导的肝损伤。
Sci Rep. 2016 Sep 26;6:34117. doi: 10.1038/srep34117.
4
Cytokines in alcoholic liver disease.细胞因子与酒精性肝病。
Arch Toxicol. 2012 Sep;86(9):1337-48. doi: 10.1007/s00204-012-0814-6. Epub 2012 Feb 25.
5
Adiponectin: a key adipokine in alcoholic fatty liver.脂联素:酒精性脂肪肝中的关键脂肪因子。
Exp Biol Med (Maywood). 2009 Aug;234(8):850-9. doi: 10.3181/0902-MR-61. Epub 2009 Jun 2.
6
Modulation of the intestinal bile acid/farnesoid X receptor/fibroblast growth factor 15 axis improves alcoholic liver disease in mice.调节肠道胆汁酸/法尼醇 X 受体/成纤维细胞生长因子 15 轴可改善小鼠的酒精性肝病。
Hepatology. 2018 Jun;67(6):2150-2166. doi: 10.1002/hep.29676. Epub 2018 Apr 16.
7
Metabolic derivatives of alcohol and the molecular culprits of fibro-hepatocarcinogenesis: Allies or enemies?酒精的代谢衍生物与纤维性肝癌发生的分子元凶:盟友还是敌人?
World J Gastroenterol. 2016 Jan 7;22(1):50-71. doi: 10.3748/wjg.v22.i1.50.
8
Anti-inflammatory pathways and alcoholic liver disease: role of an adiponectin/interleukin-10/heme oxygenase-1 pathway.抗炎途径与酒精性肝病:脂联素/白细胞介素-10/血红素加氧酶-1 途径的作用。
World J Gastroenterol. 2010 Mar 21;16(11):1330-6. doi: 10.3748/wjg.v16.i11.1330.
9
Ileal FGF15 contributes to fibrosis-associated hepatocellular carcinoma development.回肠成纤维细胞生长因子15促进与纤维化相关的肝细胞癌发展。
Int J Cancer. 2015 May 15;136(10):2469-75. doi: 10.1002/ijc.29287. Epub 2014 Nov 6.
10
The effect of fibroblast growth factor 15 deficiency on the development of high fat diet induced non-alcoholic steatohepatitis.成纤维细胞生长因子15缺乏对高脂饮食诱导的非酒精性脂肪性肝炎发展的影响。
Toxicol Appl Pharmacol. 2017 Sep 1;330:1-8. doi: 10.1016/j.taap.2017.06.023. Epub 2017 Jul 1.

引用本文的文献

1
Therapeutic Effects of Melatonin in the Regulation of Ferroptosis: A Review of Current Evidence.褪黑素在调控铁死亡中的治疗作用:对现有证据的综述。
Curr Drug Targets. 2024;25(8):543-557. doi: 10.2174/0113894501284110240426074746.
2
Relationship of serum adiponectin and resistin levels with the severity of liver fibrosis in patients with chronic hepatitis B.慢性乙型肝炎患者血清脂联素和抵抗素水平与肝纤维化严重程度的关系
J Med Biochem. 2022 Apr 8;41(2):176-183. doi: 10.5937/jomb0-33793.
3
Relationship Between Fibroblast Growth Factor 19 and Diabetic Retinopathy in Patients with Type 2 Diabetes Mellitus.2型糖尿病患者成纤维细胞生长因子19与糖尿病视网膜病变的关系
Diabetes Metab Syndr Obes. 2021 Dec 3;14:4715-4721. doi: 10.2147/DMSO.S339954. eCollection 2021.
4
Aberrant FGFR4 signaling worsens nonalcoholic steatohepatitis in FGF21KO mice.异常的 FGFR4 信号会加重 FGF21KO 小鼠的非酒精性脂肪性肝炎。
Int J Biol Sci. 2021 Jun 22;17(10):2576-2589. doi: 10.7150/ijbs.58776. eCollection 2021.
5
Effect of fucoidan on ethanol-induced liver injury and steatosis in mice and the underlying mechanism.岩藻多糖对小鼠乙醇诱导的肝损伤和脂肪变性的影响及其潜在机制。
Food Nutr Res. 2021 Apr 20;65. doi: 10.29219/fnr.v65.5384. eCollection 2021.
6
FGF19 and FGF21 for the Treatment of NASH-Two Sides of the Same Coin? Differential and Overlapping Effects of FGF19 and FGF21 From Mice to Human.成纤维细胞生长因子19和21用于非酒精性脂肪性肝炎的治疗——同一枚硬币的两面?从小鼠到人类,成纤维细胞生长因子19和21的差异与重叠效应
Front Endocrinol (Lausanne). 2020 Dec 22;11:601349. doi: 10.3389/fendo.2020.601349. eCollection 2020.
7
Roles of Adipokines in Digestive Diseases: Markers of Inflammation, Metabolic Alteration and Disease Progression.脂肪细胞因子在消化疾病中的作用:炎症、代谢改变和疾病进展的标志物。
Int J Mol Sci. 2020 Nov 5;21(21):8308. doi: 10.3390/ijms21218308.
8
Data on Adiponectin from 2010 to 2020: Therapeutic Target and Prognostic Factor for Liver Diseases?2010 年至 2020 年关于脂联素的数据:肝脏疾病的治疗靶点和预后因素?
Int J Mol Sci. 2020 Jul 23;21(15):5242. doi: 10.3390/ijms21155242.
9
Intestinal SIRT1 Deficiency Protects Mice from Ethanol-Induced Liver Injury by Mitigating Ferroptosis.肠 SIRT1 缺乏通过减轻铁死亡来保护小鼠免受乙醇诱导的肝损伤。
Am J Pathol. 2020 Jan;190(1):82-92. doi: 10.1016/j.ajpath.2019.09.012. Epub 2019 Oct 11.
10
Current and Emerging Approaches for Nonalcoholic Steatohepatitis Treatment.非酒精性脂肪性肝炎治疗的当前及新出现的方法
Gene Expr. 2019 Nov 4;19(3):175-185. doi: 10.3727/105221619X15536120524171. Epub 2019 Apr 2.

本文引用的文献

1
Organ-Organ Crosstalk and Alcoholic Liver Disease.器官-器官间的相互作用与酒精性肝病
Biomolecules. 2017 Aug 16;7(3):62. doi: 10.3390/biom7030062.
2
Mitochondrial DNA-enriched microparticles promote acute-on-chronic alcoholic neutrophilia and hepatotoxicity.富含线粒体DNA的微粒会促进慢性酒精中毒基础上的急性嗜中性粒细胞增多症和肝毒性。
JCI Insight. 2017 Jul 20;2(14). doi: 10.1172/jci.insight.92634.
3
Targeting inflammation for the treatment of alcoholic liver disease.针对炎症治疗酒精性肝病。
Pharmacol Ther. 2017 Dec;180:77-89. doi: 10.1016/j.pharmthera.2017.06.007. Epub 2017 Jun 19.
4
A postprandial FGF19-SHP-LSD1 regulatory axis mediates epigenetic repression of hepatic autophagy.餐后FGF19-SHP-LSD1调节轴介导肝脏自噬的表观遗传抑制。
EMBO J. 2017 Jun 14;36(12):1755-1769. doi: 10.15252/embj.201695500. Epub 2017 Apr 26.
5
Adiponectin partially rescues high glucose/high fat-induced impairment of mitochondrial biogenesis and function in a PGC-1α dependent manner.脂联素以依赖于PGC-1α的方式部分挽救高糖/高脂诱导的线粒体生物合成和功能损伤。
Eur Rev Med Pharmacol Sci. 2017 Jan;21(3):590-599.
6
Impact of gut hormone FGF-19 on type-2 diabetes and mitochondrial recovery in a prospective study of obese diabetic women undergoing bariatric surgery.在一项对接受减肥手术的肥胖糖尿病女性的前瞻性研究中,肠道激素FGF-19对2型糖尿病和线粒体恢复的影响。
BMC Med. 2017 Feb 16;15(1):34. doi: 10.1186/s12916-017-0797-5.
7
Fibroblast growth factor 15/19 (FGF15/19) protects from diet-induced hepatic steatosis: development of an FGF19-based chimeric molecule to promote fatty liver regeneration.成纤维细胞生长因子 15/19(FGF15/19)可预防饮食诱导的肝脂肪变性:基于 FGF19 的嵌合分子的开发以促进脂肪肝再生。
Gut. 2017 Oct;66(10):1818-1828. doi: 10.1136/gutjnl-2016-312975. Epub 2017 Jan 24.
8
Synergistic Interaction of Light Alcohol Administration in the Presence of Mild Iron Overload in a Mouse Model of Liver Injury: Involvement of Triosephosphate Isomerase Nitration and Inactivation.轻度铁过载情况下轻度饮酒对小鼠肝损伤模型的协同相互作用:磷酸丙糖异构酶硝化和失活的作用
PLoS One. 2017 Jan 19;12(1):e0170350. doi: 10.1371/journal.pone.0170350. eCollection 2017.
9
Sex Differences in Alcohol Use Disorder.酒精使用障碍中的性别差异
Curr Med Chem. 2017;24(24):2661-2670. doi: 10.2174/0929867323666161202092908.
10
Adiponectin reduces ER stress-induced apoptosis through PPARα transcriptional regulation of ATF2 in mouse adipose.脂联素通过过氧化物酶体增殖物激活受体α(PPARα)对小鼠脂肪中活化转录因子2(ATF2)的转录调控来减少内质网应激诱导的细胞凋亡。
Cell Death Dis. 2016 Nov 24;7(11):e2487. doi: 10.1038/cddis.2016.388.

乙醇诱导的炎症和酒精性肝损伤中的内分泌脂联素-FGF15/19轴

Endocrine Adiponectin-FGF15/19 Axis in Ethanol-Induced Inflammation and Alcoholic Liver Injury.

作者信息

You Min, Zhou Zhou, Daniels Michael, Jogasuria Alvin

机构信息

Department of Pharmaceutical Sciences, College of Pharmacy, Northeast Ohio Medical University, Rootstown, OH, USA.

出版信息

Gene Expr. 2018 May 18;18(2):103-113. doi: 10.3727/105221617X15093738210295. Epub 2017 Nov 2.

DOI:10.3727/105221617X15093738210295
PMID:29096734
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5953845/
Abstract

Alcoholic liver disease (ALD) is the most prevalent form of liver disease, encompassing a spectrum of progressive pathological changes from steatosis to steatohepatitis to fibrosis/cirrhosis and hepatocellular carcinoma. Alcoholic steatosis/steatohepatitis is the initial stage of ALD and a major risk factor for advanced liver injuries. Adiponectin is a hormone secreted from adipocytes. Fibroblast growth factor (FGF) 15 (human homolog, FGF19) is an ileum-derived hormone. Adipocyte-derived adiponectin and gut-derived FGF15/19 regulate each other, share common signaling cascades, and exert similar beneficial functions. Emerging evidence has revealed that dysregulated adiponectin-FGF15/19 axis and impaired hepatic adiponectin-FGF15/19 signaling are associated with alcoholic liver damage in rodents and humans. More importantly, endocrine adiponectin-FGF15/19 signaling confers protection against ethanol-induced liver damage via fine tuning the adipose-intestine-liver crosstalk, leading to limited hepatic inflammatory responses, and ameliorated alcoholic liver injury. This review is focused on the recently discovered endocrine adiponectin-FGF15/19 axis that is emerging as an essential adipose-gut-liver coordinator involved in the development and progression of alcoholic steatohepatitis.

摘要

酒精性肝病(ALD)是最常见的肝病形式,涵盖了从脂肪变性到脂肪性肝炎再到纤维化/肝硬化以及肝细胞癌的一系列渐进性病理变化。酒精性脂肪变性/脂肪性肝炎是ALD的初始阶段,也是晚期肝损伤的主要危险因素。脂联素是一种由脂肪细胞分泌的激素。成纤维细胞生长因子(FGF)15(人类同源物FGF19)是一种由回肠产生的激素。脂肪细胞衍生的脂联素和肠道衍生的FGF15/19相互调节,共享共同的信号级联,并发挥相似的有益功能。新出现的证据表明,脂联素-FGF15/19轴失调以及肝脏脂联素-FGF15/19信号受损与啮齿动物和人类的酒精性肝损伤有关。更重要的是,内分泌脂联素-FGF15/19信号通过微调脂肪-肠道-肝脏的相互作用,对乙醇诱导的肝损伤具有保护作用,从而导致肝脏炎症反应受限,并改善酒精性肝损伤。本综述聚焦于最近发现的内分泌脂联素-FGF15/19轴,该轴正成为参与酒精性脂肪性肝炎发生和发展的重要脂肪-肠道-肝脏协调因子。